Status:
TERMINATED
D-Dimer and IPG for Recurrent Thrombosis (DIRECT)
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborating Sponsors:
Heart and Stroke Foundation of Canada
Conditions:
Deep Vein Thrombosis
Pulmonary Embolism
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
To simplify and improve the diagnostic approach to patients with clinically suspected recurrent DVT by determining whether the results of the combination of IPG and d-dimer testing, using a whole bloo...
Eligibility Criteria
Inclusion
- suspected deep vein thrombosis
- history of previous DVT or PE
Exclusion
- comorbid condition limiting survival to less than 6 months
- contraindication to contrast medium (allergy, renal dysfunction, creatinine \> 150mcmol/L)
- receiving long-term warfarin or heparin therapy
- received full-dose heparin therapy for more than 48 hours
- pregnancy
- symptomatic for pulmonary embolism
- absence of symptoms within 5 days of presentation
- geographic inaccessibility which precludes follow-up
Key Trial Info
Start Date :
December 1 1998
Trial Type :
INTERVENTIONAL
End Date :
January 1 2001
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00182247
Start Date
December 1 1998
End Date
January 1 2001
Last Update
September 16 2005
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2
2
McMaster University Medical Centre
Hamilton, Ontario, Canada, L8N 3Z5
3
St. Joseph' Hospital
Hamilton, Ontario, Canada, L8N 4A6
4
Henderson General Hospital
Hamilton, Ontario, Canada, L8V 1C3